News
Prothena Corporation (NASDAQ:PRTA) is a clinical-stage neuroscience company that discovers and develops novel therapies for ...
In the span of just 52 weeks, Target (NYSE: TGT) has traded as low as $87.35 per share and as high as $167.40 per share.
In other words, Target stock is "cheap" when compared to the valuation of the S&P 500, meaning it's merely less expensive ...
Citi analyst Paul Lejuez lowered the firm’s price target on Target Corp. (NYSE:TGT) to $94 from $97, keeping a Neutral rating ...
Many investors were eager to see how retail giant Target's (NYSE: TGT) latest quarter would look, and, unfortunately, it wasn ...
1d
Zacks Investment Research on MSNWalmart vs. Target: Which Retail Giant is Poised to Outperform?Walmart Inc. WMT and Target Corporation TGT both dominate the retail landscape, offering everything from groceries and ...
Explore more
Wells Fargo lowered its price target on Target Corp. (NYSE:TGT) to $115 from $135 but kept an Overweight rating on the shares ...
One of the largest and most important dairy farms in south-eastern Mexico, covering 1562ha in the state of Campeche, is on ...
On May 22, JPMorgan analyst Christopher Horvers raised the firm’s price target on Target Corp. (NYSE: TGT) to $109 from $105 ...
Bernstein kept an Underperform rating on Target Corp. (NYSE:TGT) and lowered the associated price target to $80 from $82. The ...
Bank of America downgrades Target (TGT) to Hold, citing market share losses, margin pressures, and near-term headwinds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results